- Diagnostics
- Monday, 11 May 2020
Hangzhou Realy IgG/IgM Rapid Test Device Deployed to Global Market
On April 20,2020, Chinese People's Association for Friendship with Foreign Countries(CPAFFC) deployed a batch of anti-epidemic materials manufactured by Hangzhou Realy Tech Co. Ltd. and donated them to Bangladesh, Morocco, Malaysia and Thailand. A number of celebrities showed up and made speeches at the event, including the president of CPAFFC Lin Songtian, former Minister of Foreign Affairs Li Zhaoxing and his wife, ambassadors of four countries to China, and the famous Chinese philanthropic entrepreneur Chen Guangbiao.
"The sudden outbreak of coronavirus pandemic created an unprecedented public health crisis around the world. Now, China has brought this virus under control and obtained periodical achievement, which in turn gives other countries valuable time to prepare for the response to the epidemic. Furthermore, we have also provided the rest of the world with 'Chinese Solution' and'Chinese Prescription'," Lin Songtian and Li Zhaoxing said in their speeches.
The novel coronavirus IgG/IgM rapid detection test device in this batch of goods is manufactured by Hangzhou Realy Tech Co. Ltd. ( http://www.realytech.com/en/contact ) and was donated by the famous Chinese philanthropic entrepreneur Chen Guangbiao. The test is easy to use and takes only 10 minutes to output results without any equipment. In terms of accuracy, the specificity is as high as 99% and the sensitivity is as high as 98%. Currently this product has been included in the export list of Chinese Commerce Ministry and exported to more than 50 countries and regions including the US, Italy, German, Russia and the United Arab Emirates.
Advantages of Realy IgG / IgM rapid Detection
- Indicating both recent infections and previous infections, reducing missed detection rates.
- No requirements of instruments; suitable for primary hospitals and conventional outpatient clinics.
- Blood testing; no special virus collection tube required.
Both IgM and IgG are immunoglobulin produced by the immune system to provide protection against the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test, indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV. During the outbreak period of 2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommended diagnostic methods.
Related Industry Updates
Phosphorus Announces In-Home COVID-19 Viral And Antibody Testing Service In New York Metropolitan Area
May 19, 2020
QiSant™ Initial Publication Demonstrates Strong Clinical Validation of Urine-Based Assay in Kidney Transplant Surveillance
Mar 19, 2020
North America Anti-Viral Therapies Market Growth Focusing on Trends & Innovations During the Period Until 2027
Dec 18, 2020
Yuyu Pharma will export COVID-19 test sets from SD BIOSENSOR to the world market
Jun 18, 2020
Mobile COVID-19 testing set for Bolivar, Yazoo, Montgomery, Perry and Claiborne counties
Apr 20, 2020
QuEST Global Enhances its Lung Nodule Detection Solution Using Microsoft Azure IoT Central, Azure IoT Edge and Azure Machine Learning
Jun 12, 2020
CooperRiis Launches New Insurance Driven Intensive Clinical Program
Jul 09, 2020